Patients diagnosed as having long COVID and myalgic encephalitis/chronic fatigue syndrome (ME/CFS) reported that most symptoms remained severe up to 20 months after SARS-CoV-2 infection, while those with long COVID alone reported improvement, according to…
Hospitalized US patients who had a type of heart attack called non–ST segment elevation myocardial infarction (NSTEMI) were at a 51% higher risk of death by 30 days and 32% higher risk of release to non-home settings amid COVID-19 patient…
When US Food and Drug Administration (FDA) inspectors visited Integra LifeSciences' drug manufacturing facility in Boston in March through May, the company's collagen-based Durepair product failed bacterial endotoxin testing. The FDA issued a warning letter to the…
A survey of more than 3.9 million US patients hospitalized amid the COVID-19 pandemic in 2020 to 2021 showed a worsening in the perceived quality of patient care, particularly in hospitals with lower prepandemic staffing and performance…
In the United States, a slow but steady rise in COVID activity continued over the past week according to the latest data from the Centers for Disease Control and Prevention (CDC), while at the global level, the…
A study led by Johns Hopkins University researchers suggests that the use of pulse oximeters in hospitalized COVID-19 patients often overestimated true arterial oxygen saturation (SaO2), especially in those of minority race, and led to delayed therapy in…
The COVID-19 pandemic did not affect all US families the same way, a new cohort study in JAMA Network Open claims, with families helmed by caregivers with lower levels of education more strained during the first 2 years of…
Today in Morbidity and Mortality Weekly Report, researchers show that teens born in 2008, who were ages 11 and 12 in 2020, have significant gaps in vaccine coverage for three common immunizations, including the tetanus, diphtheria, and acellular pertussis…
The US Centers for Disease Control and Prevention (CDC) today issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able…
The US Food and Drug Administration (FDA) yesterday announced its approval for the use of Pfizer's new respiratory syncytial virus (RSV) vaccine in pregnant women to help protect infants as old as 6 months old, marking a…
